Trade Summary

1 week ago, Tsai Philip, serving as Chief Technical Officer at Immunome Inc. (IMNM), purchased 10,000 shares at $20.49 per share, for a total transaction value of $204,900.00. Following this transaction, Tsai Philip now holds 43,300 shares of IMNM.

This purchase represents a 30.00% increase in Tsai Philip's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, December 19, 2025 and publicly disclosed via SEC Form 4 filing on Monday, December 22, 2025, 3 days after the trade was made.

Immunome Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.